当前位置:阿仪网 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > MCE信号通路 > 蛋白偶联受体/G 蛋白 > Ambrisentan sodium

Ambrisentan (BSF 208075) sodium 是一种选择性的、具有口服活性的 ET A 型受体 (ETAR) 拮抗剂。
服务

产品完善度:
更新时间:2026/10/7 8:46:25关注度:2043
关键词标签:BSF,208075,sodium
支付方式:
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1386915-48-5
MCE 国际站:Ambrisentan sodium
产品活性:Ambrisentan (BSF 208075) sodium 是一种选择性的、具有口服活性的 ET A 型受体 (ETAR) 拮抗剂。
研究领域:GPCR/G Protein
作用靶点:Endothelin Receptor
In Vitro: Ambrisentan sodium is an endothelin type A receptor antagonist.
Ambrisentan sodium induces Nrf2 activation. Endothelial permeability increased in BMEC monolayers at 24 h of hypoxia exposure and compared to vehicle control, Ambrisentan attenuates hypoxia-induced BMEC leak. These results are reversed when prior to treatment BMEC are transfected with siRNA against Nrf2.
In Vivo: In the Ambrisentan group, hepatic hydroxyproline content is significantly lower than in the control group (18.0 µg/g±6.1 µg/g vs 33.9 µg/g±13.5 µg/g liver, respectively, P=0.014). Hepatic fibrosis estimated by Sirius red staining and areas positive for α-smooth muscle actin, indicative of activated hepatic stellate cells, are also significantly lower in the Ambrisentan group (0.46%±0.18% vs 1.11%±0.28%, respectively, P=0.0003; and 0.12%±0.08% vs 0.25%±0.11%, respectively, P=0.047). Moreover, hepatic RNA expression levels of procollagen-1 and tissue inhibitor of metalloproteinase-1 (TIMP-1) are significantly lower by 60% and 45%, respectively, in the Ambrisentan group. Inflammation, steatosis, and endothelin-related mRNA expression in the liver are not significantly different between the groups. Ambrisentan sodium attenuates the progression of hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing procollagen-1 and TIMP-1 gene expression. Ambrisentan sodium did not affect inflammation or steatosis.
相关产品:Endothelin 1 (swine, human) | Bosentan | Macitentan | BQ⁻⁷88 sodium salt | Atrasentan hydrochloride | BQ-123 | Ambrisentan | Carperitide acetate | Sparsentan | A-192621 | Sitaxsentan sodium | Sulfisoxazole | Zibotentan | Avosentan | IRL-1620 TFA | Atrial Natriuretic Peptide (ANP) (1-28), rat | BQ-3020 TFA | IRL 2500 | Aprocitentan | Nebentan potassium | Darusentan
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 染料试剂 | PROTAC | 同位素标记物 | 寡核苷酸
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
推荐产品